line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,79381724.503713,SYNGENE.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.248068,SYNGENE.NS
Normalized EBITDA,2025-03-31 00:00:00,11136000000.0,SYNGENE.NS
Total Unusual Items,2025-03-31 00:00:00,320000000.0,SYNGENE.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,320000000.0,SYNGENE.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,4962000000.0,SYNGENE.NS
Reconciled Depreciation,2025-03-31 00:00:00,4326000000.0,SYNGENE.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,9425000000.0,SYNGENE.NS
EBITDA,2025-03-31 00:00:00,11456000000.0,SYNGENE.NS
EBIT,2025-03-31 00:00:00,7130000000.0,SYNGENE.NS
Net Interest Income,2025-03-31 00:00:00,-531000000.0,SYNGENE.NS
Interest Expense,2025-03-31 00:00:00,531000000.0,SYNGENE.NS
Interest Income,2025-03-31 00:00:00,,SYNGENE.NS
Normalized Income,2025-03-31 00:00:00,4721381724.503713,SYNGENE.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,4962000000.0,SYNGENE.NS
Total Expenses,2025-03-31 00:00:00,30313000000.0,SYNGENE.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,SYNGENE.NS
Diluted Average Shares,2025-03-31 00:00:00,,SYNGENE.NS
Basic Average Shares,2025-03-31 00:00:00,,SYNGENE.NS
Diluted EPS,2025-03-31 00:00:00,,SYNGENE.NS
Basic EPS,2025-03-31 00:00:00,,SYNGENE.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,4962000000.0,SYNGENE.NS
Net Income Common Stockholders,2025-03-31 00:00:00,4962000000.0,SYNGENE.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,SYNGENE.NS
Net Income,2025-03-31 00:00:00,4962000000.0,SYNGENE.NS
Minority Interests,2025-03-31 00:00:00,,SYNGENE.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,4962000000.0,SYNGENE.NS
Net Income Continuous Operations,2025-03-31 00:00:00,4962000000.0,SYNGENE.NS
Tax Provision,2025-03-31 00:00:00,1637000000.0,SYNGENE.NS
Pretax Income,2025-03-31 00:00:00,6599000000.0,SYNGENE.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,718000000.0,SYNGENE.NS
Special Income Charges,2025-03-31 00:00:00,320000000.0,SYNGENE.NS
Other Special Charges,2025-03-31 00:00:00,,SYNGENE.NS
Write Off,2025-03-31 00:00:00,,SYNGENE.NS
Restructuring And Mergern Acquisition,2025-03-31 00:00:00,,SYNGENE.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-531000000.0,SYNGENE.NS
Interest Expense Non Operating,2025-03-31 00:00:00,531000000.0,SYNGENE.NS
Interest Income Non Operating,2025-03-31 00:00:00,,SYNGENE.NS
Operating Income,2025-03-31 00:00:00,6111000000.0,SYNGENE.NS
Operating Expense,2025-03-31 00:00:00,20888000000.0,SYNGENE.NS
Other Operating Expenses,2025-03-31 00:00:00,6723000000.0,SYNGENE.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,4326000000.0,SYNGENE.NS
Amortization,2025-03-31 00:00:00,,SYNGENE.NS
Depreciation Income Statement,2025-03-31 00:00:00,4326000000.0,SYNGENE.NS
Selling General And Administration,2025-03-31 00:00:00,,SYNGENE.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,SYNGENE.NS
General And Administrative Expense,2025-03-31 00:00:00,,SYNGENE.NS
Rent And Landing Fees,2025-03-31 00:00:00,,SYNGENE.NS
Gross Profit,2025-03-31 00:00:00,26999000000.0,SYNGENE.NS
Cost Of Revenue,2025-03-31 00:00:00,9425000000.0,SYNGENE.NS
Total Revenue,2025-03-31 00:00:00,36424000000.0,SYNGENE.NS
Operating Revenue,2025-03-31 00:00:00,36424000000.0,SYNGENE.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,-19811211.340206,SYNGENE.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.178479,SYNGENE.NS
Normalized EBITDA,2024-03-31 00:00:00,11050000000.0,SYNGENE.NS
Total Unusual Items,2024-03-31 00:00:00,-111000000.0,SYNGENE.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,-111000000.0,SYNGENE.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,5100000000.0,SYNGENE.NS
Reconciled Depreciation,2024-03-31 00:00:00,4259000000.0,SYNGENE.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,9302000000.0,SYNGENE.NS
EBITDA,2024-03-31 00:00:00,10939000000.0,SYNGENE.NS
EBIT,2024-03-31 00:00:00,6680000000.0,SYNGENE.NS
Net Interest Income,2024-03-31 00:00:00,-314000000.0,SYNGENE.NS
Interest Expense,2024-03-31 00:00:00,472000000.0,SYNGENE.NS
Interest Income,2024-03-31 00:00:00,158000000.0,SYNGENE.NS
Normalized Income,2024-03-31 00:00:00,5191188788.659794,SYNGENE.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,5100000000.0,SYNGENE.NS
Total Expenses,2024-03-31 00:00:00,28443000000.0,SYNGENE.NS
Rent Expense Supplemental,2024-03-31 00:00:00,55000000.0,SYNGENE.NS
Diluted Average Shares,2024-03-31 00:00:00,401891253.0,SYNGENE.NS
Basic Average Shares,2024-03-31 00:00:00,401258851.0,SYNGENE.NS
Diluted EPS,2024-03-31 00:00:00,12.69,SYNGENE.NS
Basic EPS,2024-03-31 00:00:00,12.71,SYNGENE.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,5100000000.0,SYNGENE.NS
Net Income Common Stockholders,2024-03-31 00:00:00,5100000000.0,SYNGENE.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,SYNGENE.NS
Net Income,2024-03-31 00:00:00,5100000000.0,SYNGENE.NS
Minority Interests,2024-03-31 00:00:00,0.0,SYNGENE.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,5100000000.0,SYNGENE.NS
Net Income Continuous Operations,2024-03-31 00:00:00,5100000000.0,SYNGENE.NS
Tax Provision,2024-03-31 00:00:00,1108000000.0,SYNGENE.NS
Pretax Income,2024-03-31 00:00:00,6208000000.0,SYNGENE.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,748000000.0,SYNGENE.NS
Special Income Charges,2024-03-31 00:00:00,-111000000.0,SYNGENE.NS
Other Special Charges,2024-03-31 00:00:00,136000000.0,SYNGENE.NS
Write Off,2024-03-31 00:00:00,6000000.0,SYNGENE.NS
Restructuring And Mergern Acquisition,2024-03-31 00:00:00,111000000.0,SYNGENE.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-314000000.0,SYNGENE.NS
Interest Expense Non Operating,2024-03-31 00:00:00,472000000.0,SYNGENE.NS
Interest Income Non Operating,2024-03-31 00:00:00,158000000.0,SYNGENE.NS
Operating Income,2024-03-31 00:00:00,6443000000.0,SYNGENE.NS
Operating Expense,2024-03-31 00:00:00,19141000000.0,SYNGENE.NS
Other Operating Expenses,2024-03-31 00:00:00,5995000000.0,SYNGENE.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,4259000000.0,SYNGENE.NS
Amortization,2024-03-31 00:00:00,79000000.0,SYNGENE.NS
Depreciation Income Statement,2024-03-31 00:00:00,4259000000.0,SYNGENE.NS
Selling General And Administration,2024-03-31 00:00:00,1697000000.0,SYNGENE.NS
Selling And Marketing Expense,2024-03-31 00:00:00,203000000.0,SYNGENE.NS
General And Administrative Expense,2024-03-31 00:00:00,1494000000.0,SYNGENE.NS
Rent And Landing Fees,2024-03-31 00:00:00,55000000.0,SYNGENE.NS
Gross Profit,2024-03-31 00:00:00,25584000000.0,SYNGENE.NS
Cost Of Revenue,2024-03-31 00:00:00,9302000000.0,SYNGENE.NS
Total Revenue,2024-03-31 00:00:00,34886000000.0,SYNGENE.NS
Operating Revenue,2024-03-31 00:00:00,34886000000.0,SYNGENE.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,4578000.0,SYNGENE.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.218,SYNGENE.NS
Normalized EBITDA,2023-03-31 00:00:00,9925000000.0,SYNGENE.NS
Total Unusual Items,2023-03-31 00:00:00,21000000.0,SYNGENE.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,21000000.0,SYNGENE.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,4644000000.0,SYNGENE.NS
Reconciled Depreciation,2023-03-31 00:00:00,3665000000.0,SYNGENE.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,8602000000.0,SYNGENE.NS
EBITDA,2023-03-31 00:00:00,9946000000.0,SYNGENE.NS
EBIT,2023-03-31 00:00:00,6281000000.0,SYNGENE.NS
Net Interest Income,2023-03-31 00:00:00,258000000.0,SYNGENE.NS
Interest Expense,2023-03-31 00:00:00,345000000.0,SYNGENE.NS
Interest Income,2023-03-31 00:00:00,603000000.0,SYNGENE.NS
Normalized Income,2023-03-31 00:00:00,4627578000.0,SYNGENE.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,4644000000.0,SYNGENE.NS
Total Expenses,2023-03-31 00:00:00,24620000000.0,SYNGENE.NS
Rent Expense Supplemental,2023-03-31 00:00:00,44000000.0,SYNGENE.NS
Diluted Average Shares,2023-03-31 00:00:00,403620257.0,SYNGENE.NS
Basic Average Shares,2023-03-31 00:00:00,400658428.0,SYNGENE.NS
Diluted EPS,2023-03-31 00:00:00,11.51,SYNGENE.NS
Basic EPS,2023-03-31 00:00:00,11.59,SYNGENE.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,4644000000.0,SYNGENE.NS
Net Income Common Stockholders,2023-03-31 00:00:00,4644000000.0,SYNGENE.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,SYNGENE.NS
Net Income,2023-03-31 00:00:00,4644000000.0,SYNGENE.NS
Minority Interests,2023-03-31 00:00:00,0.0,SYNGENE.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,4644000000.0,SYNGENE.NS
Net Income Continuous Operations,2023-03-31 00:00:00,4644000000.0,SYNGENE.NS
Tax Provision,2023-03-31 00:00:00,1292000000.0,SYNGENE.NS
Pretax Income,2023-03-31 00:00:00,5936000000.0,SYNGENE.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,709000000.0,SYNGENE.NS
Special Income Charges,2023-03-31 00:00:00,-85000000.0,SYNGENE.NS
Other Special Charges,2023-03-31 00:00:00,75000000.0,SYNGENE.NS
Write Off,2023-03-31 00:00:00,10000000.0,SYNGENE.NS
Restructuring And Mergern Acquisition,2023-03-31 00:00:00,,SYNGENE.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,258000000.0,SYNGENE.NS
Interest Expense Non Operating,2023-03-31 00:00:00,345000000.0,SYNGENE.NS
Interest Income Non Operating,2023-03-31 00:00:00,603000000.0,SYNGENE.NS
Operating Income,2023-03-31 00:00:00,6182000000.0,SYNGENE.NS
Operating Expense,2023-03-31 00:00:00,16018000000.0,SYNGENE.NS
Other Operating Expenses,2023-03-31 00:00:00,3727000000.0,SYNGENE.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,3665000000.0,SYNGENE.NS
Amortization,2023-03-31 00:00:00,58000000.0,SYNGENE.NS
Depreciation Income Statement,2023-03-31 00:00:00,3607000000.0,SYNGENE.NS
Selling General And Administration,2023-03-31 00:00:00,1236000000.0,SYNGENE.NS
Selling And Marketing Expense,2023-03-31 00:00:00,185000000.0,SYNGENE.NS
General And Administrative Expense,2023-03-31 00:00:00,1051000000.0,SYNGENE.NS
Rent And Landing Fees,2023-03-31 00:00:00,44000000.0,SYNGENE.NS
Gross Profit,2023-03-31 00:00:00,22200000000.0,SYNGENE.NS
Cost Of Revenue,2023-03-31 00:00:00,8602000000.0,SYNGENE.NS
Total Revenue,2023-03-31 00:00:00,30802000000.0,SYNGENE.NS
Operating Revenue,2023-03-31 00:00:00,30802000000.0,SYNGENE.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,-49776000.0,SYNGENE.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.183,SYNGENE.NS
Normalized EBITDA,2022-03-31 00:00:00,8388000000.0,SYNGENE.NS
Total Unusual Items,2022-03-31 00:00:00,-272000000.0,SYNGENE.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,-272000000.0,SYNGENE.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,3958000000.0,SYNGENE.NS
Reconciled Depreciation,2022-03-31 00:00:00,3097000000.0,SYNGENE.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,7490000000.0,SYNGENE.NS
EBITDA,2022-03-31 00:00:00,8116000000.0,SYNGENE.NS
EBIT,2022-03-31 00:00:00,5019000000.0,SYNGENE.NS
Net Interest Income,2022-03-31 00:00:00,290000000.0,SYNGENE.NS
Interest Expense,2022-03-31 00:00:00,175000000.0,SYNGENE.NS
Interest Income,2022-03-31 00:00:00,465000000.0,SYNGENE.NS
Normalized Income,2022-03-31 00:00:00,4180224000.0,SYNGENE.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,3958000000.0,SYNGENE.NS
Total Expenses,2022-03-31 00:00:00,20723000000.0,SYNGENE.NS
Rent Expense Supplemental,2022-03-31 00:00:00,48000000.0,SYNGENE.NS
Diluted Average Shares,2022-03-31 00:00:00,402897208.0,SYNGENE.NS
Basic Average Shares,2022-03-31 00:00:00,398148760.0,SYNGENE.NS
Diluted EPS,2022-03-31 00:00:00,9.82,SYNGENE.NS
Basic EPS,2022-03-31 00:00:00,9.94,SYNGENE.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,3958000000.0,SYNGENE.NS
Net Income Common Stockholders,2022-03-31 00:00:00,3958000000.0,SYNGENE.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,SYNGENE.NS
Net Income,2022-03-31 00:00:00,3958000000.0,SYNGENE.NS
Minority Interests,2022-03-31 00:00:00,0.0,SYNGENE.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,3958000000.0,SYNGENE.NS
Net Income Continuous Operations,2022-03-31 00:00:00,3958000000.0,SYNGENE.NS
Tax Provision,2022-03-31 00:00:00,886000000.0,SYNGENE.NS
Pretax Income,2022-03-31 00:00:00,4844000000.0,SYNGENE.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,528000000.0,SYNGENE.NS
Special Income Charges,2022-03-31 00:00:00,-335000000.0,SYNGENE.NS
Other Special Charges,2022-03-31 00:00:00,327000000.0,SYNGENE.NS
Write Off,2022-03-31 00:00:00,8000000.0,SYNGENE.NS
Restructuring And Mergern Acquisition,2022-03-31 00:00:00,,SYNGENE.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,290000000.0,SYNGENE.NS
Interest Expense Non Operating,2022-03-31 00:00:00,175000000.0,SYNGENE.NS
Interest Income Non Operating,2022-03-31 00:00:00,465000000.0,SYNGENE.NS
Operating Income,2022-03-31 00:00:00,4344000000.0,SYNGENE.NS
Operating Expense,2022-03-31 00:00:00,13233000000.0,SYNGENE.NS
Other Operating Expenses,2022-03-31 00:00:00,2922000000.0,SYNGENE.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,3097000000.0,SYNGENE.NS
Amortization,2022-03-31 00:00:00,67000000.0,SYNGENE.NS
Depreciation Income Statement,2022-03-31 00:00:00,3030000000.0,SYNGENE.NS
Selling General And Administration,2022-03-31 00:00:00,910000000.0,SYNGENE.NS
Selling And Marketing Expense,2022-03-31 00:00:00,117000000.0,SYNGENE.NS
General And Administrative Expense,2022-03-31 00:00:00,793000000.0,SYNGENE.NS
Rent And Landing Fees,2022-03-31 00:00:00,48000000.0,SYNGENE.NS
Gross Profit,2022-03-31 00:00:00,17577000000.0,SYNGENE.NS
Cost Of Revenue,2022-03-31 00:00:00,7490000000.0,SYNGENE.NS
Total Revenue,2022-03-31 00:00:00,25067000000.0,SYNGENE.NS
Operating Revenue,2022-03-31 00:00:00,25067000000.0,SYNGENE.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,SYNGENE.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,SYNGENE.NS
Normalized EBITDA,2021-03-31 00:00:00,,SYNGENE.NS
Total Unusual Items,2021-03-31 00:00:00,,SYNGENE.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,SYNGENE.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,SYNGENE.NS
Reconciled Depreciation,2021-03-31 00:00:00,,SYNGENE.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,SYNGENE.NS
EBITDA,2021-03-31 00:00:00,,SYNGENE.NS
EBIT,2021-03-31 00:00:00,,SYNGENE.NS
Net Interest Income,2021-03-31 00:00:00,,SYNGENE.NS
Interest Expense,2021-03-31 00:00:00,,SYNGENE.NS
Interest Income,2021-03-31 00:00:00,623000000.0,SYNGENE.NS
Normalized Income,2021-03-31 00:00:00,,SYNGENE.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,SYNGENE.NS
Total Expenses,2021-03-31 00:00:00,,SYNGENE.NS
Rent Expense Supplemental,2021-03-31 00:00:00,38000000.0,SYNGENE.NS
Diluted Average Shares,2021-03-31 00:00:00,400668505.0,SYNGENE.NS
Basic Average Shares,2021-03-31 00:00:00,397725075.0,SYNGENE.NS
Diluted EPS,2021-03-31 00:00:00,10.11,SYNGENE.NS
Basic EPS,2021-03-31 00:00:00,10.18,SYNGENE.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,SYNGENE.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,SYNGENE.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,SYNGENE.NS
Net Income,2021-03-31 00:00:00,,SYNGENE.NS
Minority Interests,2021-03-31 00:00:00,0.0,SYNGENE.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,SYNGENE.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,SYNGENE.NS
Tax Provision,2021-03-31 00:00:00,,SYNGENE.NS
Pretax Income,2021-03-31 00:00:00,,SYNGENE.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,SYNGENE.NS
Special Income Charges,2021-03-31 00:00:00,,SYNGENE.NS
Other Special Charges,2021-03-31 00:00:00,-291000000.0,SYNGENE.NS
Write Off,2021-03-31 00:00:00,16000000.0,SYNGENE.NS
Restructuring And Mergern Acquisition,2021-03-31 00:00:00,,SYNGENE.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,SYNGENE.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,SYNGENE.NS
Interest Income Non Operating,2021-03-31 00:00:00,623000000.0,SYNGENE.NS
Operating Income,2021-03-31 00:00:00,,SYNGENE.NS
Operating Expense,2021-03-31 00:00:00,,SYNGENE.NS
Other Operating Expenses,2021-03-31 00:00:00,,SYNGENE.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,SYNGENE.NS
Amortization,2021-03-31 00:00:00,73000000.0,SYNGENE.NS
Depreciation Income Statement,2021-03-31 00:00:00,,SYNGENE.NS
Selling General And Administration,2021-03-31 00:00:00,660000000.0,SYNGENE.NS
Selling And Marketing Expense,2021-03-31 00:00:00,64000000.0,SYNGENE.NS
General And Administrative Expense,2021-03-31 00:00:00,596000000.0,SYNGENE.NS
Rent And Landing Fees,2021-03-31 00:00:00,38000000.0,SYNGENE.NS
Gross Profit,2021-03-31 00:00:00,,SYNGENE.NS
Cost Of Revenue,2021-03-31 00:00:00,,SYNGENE.NS
Total Revenue,2021-03-31 00:00:00,,SYNGENE.NS
Operating Revenue,2021-03-31 00:00:00,,SYNGENE.NS
